Email

corriec@bcm.edu

Positions

Associate Professor

Pediatrics
Emergency Medicine
Baylor College of Medicine
Houston, Texas United States

Addresses

Texas Children's Hospital (Hospital)

6621 Fannin Street, Suite A2210
Houston, TX 77030
United States
Phone: (832) 824-5497

Education

MD from University Of Wisconsin, Madison

06/2004 - Madison, WI United States

Fellowship at Baylor College of Medicine

06/2010 - Houston, TX

Pediatric Emergency Medicine

Residency at Massachusetts General Hospital

06/2007 - Boston, MA

Pediatrics

Internship at Massachusetts General Hospital

06/2005 - Boston, MA

Pediatrics

MS from University of Texas Health Science Center

12/2017 - Houston, Texas United States

BA from DePauw University

05/1999 - Greencastle, Indiana United States

Certifications

PALS Instructor

(01/01/2014)

American Heart Association

ACLS

ATLS

Honors & Awards

Fulbright and Jaworski LLP Faculty Excellence Award for Teaching and Evaluation 2016

Baylor College of Medicine (05/2016)

Norton Rose Fulbright Faculty Excellence Award for Development of Enduring Educational Materials

Baylor College of Medicine (10/2016)

Section of Emergency Medicine Super Star Award

Baylor College of Medicine (06/2017)

Joseph P Cravero Award Nominee

Society for Pediatric Sedation (05/2016)

Top Pediatric Emergency Medicine Doctors

Houstonia Magazine (08/2012 - 08/2017)

SuperStar Award

Texas Children's Hospital Section of Emergency Medicine (06/2016)

Outstanding Clinician Award

Awarded annually to a Department of Pediatrics faculty recognized by peers as an exceptional clinician providing the highest quality medical care to patients

Texas Children's Hospital (04/2018)

Star Award

Awarded to Faculty who display Excellence in Patient Care

Baylor College of Medicine (05/2018)

Professional Interests

• Pediatric Sedation
• Pain Management
• Medical Simulation

Websites

Selected Publications

• Brousseau DC, Scott JP, Badaki-Makun O, Darbari DS, Chumpitazi CE "A multi-center randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children." Blood. 2015 Jul 31; Pubmed PMID: 26232172
• Grunwell JR, Travers , McCracken CE, Scherrer P, Stormorken A, Chumpitazi CE, Roback M, Stockwell, and Kamat PP "Procedural Sedation Outside the Operating Room Using Ketamine in 22,645 Children: A Report from the Pediatric Sedation Research Consortium." Pediatr Crit Care Med. 2016 Dec 17;12 Pubmed PMID: 27505726
• Chumpitazi CE, Rees CA, Camp EA, Valdez K, Choi B, Chumpitazi BP, Pereira F "Influencing Drainage Setting and Cost for Cutaneous Abscesses among Pediatric Patients. Am J Emerg Med." Am J Emerg Med. 2017; Pubmed PMID: 28029490
• Khalil SN, Hahn BJ, Chumpitazi CE, Rock AD, Kaelin BA, Macias CG "A Multicenter, Randomized, Open-Label, Active-Comparator Trial to Determine the Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen for Treatment of Fever in Hospitalized Pediatric Patients." BMC Pediatrics.; Pubmed PMID: 28143430

Memberships

Society for Pediatric Sedation

Provider Course Committee Chair (01/2008)

American Academy of Pediatrics

Section of Emergency Medicine (07/2007)

American College of Emergency Physicians

Section of Pediatrics (05/2009)

Society for Academic Emergency Medicine

Research Committee (08/2015)

Funding

Emergency Medical Services for Children Innovation and Improvement Center - #170230239

$10,000,000.00 (07/01/2020 - 06/30/2024)

Grant funding from Health Related Services Administration

EMS for Children Innovation and Improvement Center (EIIC) leverages partnerships with national professional organizations to provide EMSC grantees and the emergency care community with training, support and tools to improve pediatric emergency care delivery across diverse emergency care systems across the continuum of care. With a growing body of evidence-based resources, the EIIC uses an enhanced and innovative approach to knowledge dissemination that utilizes novel technologies, subject matter expertise in the development of resources, and quality improvement (QI) methodology to minimize morbidity and mortality due to illness and injury in children. With a heavy emphasis on the prehospital and hospital based community, the EIIC’s effort will also target the lay public, ESMC stakeholders, advocates and the scientific community. Services: A systems-based approach will be used to align priorities and efforts across organizations and domains of emergency care: trauma, hospital, prehospital, disaster preparedness, research, and state/territory-based EMSC programs. Matrixed with these core domains and a team-of-teams approach are knowledge management, QI collaboratives, advocacy, analytics, and value-based care. The co-principal investigators from Dell Medical School, The University of Texas at Austin, Austin, TX, and University Hospitals Rainbow Babies and Children’s Hospital, Cleveland, OH in conjunction with co-investigators from Yale University School of Medicine, the Lundquist Institute for Biomedical Innovation at Harbor UCLA, and Baylor College of Medicine/Texas Children’s Hospital, together will expand the existing EIIC partnerships to include the Emergency Nurses Association, National Association of State EMS Officials, the American Academy of Pediatrics, the American College of Emergency Physicians, and the American College of Surgeons. National QI collaboratives, dissemination toolkits, novel educational platforms, and innovative communication techniques will be used to drive expansion and enhancement of the pediatric emergency care workforce, integration of best practices, and ultimately adoption of evidence based strategies to decrease pediatric morbidity and mortality.

Bedside Exclusion of Pulmonary Emboli in Children without Exposure to Radiation - #1R01-HL148247 01A1

$7,882,615.00 (08/21/2020 - 06/30/2025)

Grant funding from NIH

This PECARN study is a prospective, observational cohort study of children ages 4 to 17 years old who have sufficiently high probability of pulmonary embolism (PE) to warrant objective diagnostic testing with a D-dimer or pulmonary vascular imaging. The goal is to measure the diagnostic accuracy of a prediction rule for exclusion of PE and the D-dimer.

1UG3HL148560-01A1 - #1UG3HL148560-01A1

$8,700,000.00 (08/01/2020 - 08/01/2025)

Grant funding from NIH

Sickle Cell Disease is an "arginine deficiency syndrome" associated with early mortality & Vaso-occlusive Episodes . Increased arginase activity from both inflammatory triggers & more significantly from erythrocyte-arginase release during hemolysis, leads to low arginine bioavailability. Although mechanisms of arginine dysregulation are complex & multifactorial, they can be overcome through arginine supplementation, a phenomenon known as the 'arginine paradox'. In transgenic mouse models of SCD, arginine supplementation inhibits the red cell Gardos channels, reduces red cell density, improves perfusion and reduces lung injury, microvascular vaso-occlusion and mortality. We therefore hypothesize that L-arginine is a safe and efficacious intervention to alter the vaso-occlusive physiology and improve care for children with VOEs.

Languages

Spanish